• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
Temsirolimus

Temsirolimus

Product ID T176503
Cas No. 162635-04-3
Purity ≥98%
Product Unit SizeCostQuantityStock
5 mg $99.80 In stock
25 mg $341.30 In stock
100 mg $892.50 In stock
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

Temsirolimus is an analog of rapamycin found to be active against several cancer types. Like rapamycin, temsirolimus is also an mTOR inhibitor. Temsirolimus has shown activity against brain, rhabdomyosarcoma, multiple myeloma, breast, tuberous sclerosis complex, acute lymphoblastic leukemia, pancreatic, prostate, neuroendocrine, renal cell carcinoma, neuroblastoma, and several other cancer types. When treated with temsirolimus, oral squamous cell carcinoma cell’s proliferation and migration were inhibited in vitro and growth of xenografts was suppressed in vivo. Furthermore, in animal models of Parkinson’s disease, treatment with temsirolimus led to increased expression of markers including tyrosine hydroxylase and dopamine transporter and also decreased the upregulation of alpha-synuclein in the substantia nigra after MPTP-induced neurotoxicity. Temsirolimus was found to modulate the autophagic process and the neuroinflammatory pathway in Parkinson’s disease, demonstrating a neuroprotective effect.

Product Info

Cas No.

162635-04-3

Purity

≥98%

Formula

C56H87NO16

Formula Wt.

1030.30

Chemical Name

Temsirolimus

IUPAC Name

[(1~{R},2~{R},4~{S})-4-[(2~{R})-2-[(1~{R},9~{S},12~{S},15~{R},16~{E},18~{R},19~{R},21~{R},23~{S},24~{Z},26~{E},28~{E},30~{S},32~{S},35~{R})-1,18-dihydroxy-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-2,3,10,14,20-pentaoxo-11,36-dioxa-4-azatricyclo[30.3.1.0^{4,9}]hexatriaconta-16,24,26,28-tetraen-12-yl]propyl]-2-methoxycyclohexyl] 3-hydroxy-2-(hydroxymethyl)-2-methylpropanoate

Synonym

CCI-779; NSC 683864; rapamycin, 42-(3-hydroxy-2-(hydroxymethyl)-2-methylpropanoate)

Shipping and Storage

Store Temp

4°C

Ship Temp

Ambient

Downloads

MSDS

T176503 MSDS PDF

Info Sheet

T176503 Info Sheet PDF

References

Geoerger B, Kerr K, Tang CB, et al. Antitumor activity of the rapamycin analog CCI-779 in human primitive neuroectodermal tumor/medulloblastoma models as single agent and in combination chemotherapy. Cancer Res. 2001 Feb 15;61(4):1527-1532. PMID: 11245461.

Gera JF, Mellinghoff IK, Shi Y, et al. AKT activity determines sensitivity to mammalian target of rapamycin (mTOR) inhibitors by regulating cyclin D1 and c-myc expression. J Biol Chem. 2004 Jan 23;279(4):2737-2746. PMID: 14576155.

Okui T, Shimo T, Fukazawa T, et al. Antitumor effect of temsirolimus against oral squamous cell carcinoma associated with bone destruction. Mol Cancer Ther. 2010 Nov;9(11):2960-2969. PMID: 20858724.

Siracusa R, Paterniti I, Cordaro M, et al. Neuroprotective effects of temsirolimus in animal models of Parkinson’s disease. Mol Neurobiol. 2018 Mar;55(3):2403-2419. PMID: 28357809.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • B3278

    Biotin

    Water-soluble coenzyme, vitamin (B7) found in v...

    ≥98%
  • M3196

    MHY-1485

    mTOR activator.

    ≥98%
  • L337521

    Linagliptin

    Modifies microvascular function

    ≥98%
  • C9863

    Cyproconazole

    Triazole; 14-α demethylase inhibitor, voltage-...

    ≥95%
  • T3040

    Thienylpentyl Isothiocyanate

    Thienylbutyl ITC analog.

    ≥98%
  • L930280

    LXH254

    pan-RAF inhibitor

    ≥99%
  • R5611

    Rocuronium Bromide

    Non-depolarizing NMJ blocker; nAChR and M2/3 mA...

    ≥98%
  • B8072

    3-tert-Butyl-5-Methoxycatechol

    BHA derivative, cellular differentiation induce...

    ≥95%
  • P0246

    Palomid 529

    mTOR inhibitor.

    ≥98%
  • F4480

    5-Fluorouracil

    Pyrimidine analog; inhibits thymidylate synthas...

    ≥98%
  • T2935

    Thiamphenicol

    Chloramphenicol derivative; protein translation...

    ≥98%
  • K5606

    Kobe 2602

    Ras inhibitor.

    ≥98%
  • F1607

    Febuxostat

    Xanthine oxidase inhibitor.

    ≥98%
  • D0263

    Dapoxetine Hydrochloride

    SERT inhibitor, potential voltage-gated K+ chan...

    ≥99%
  • I7459

    1-Isothiocyanato-8-(methylsulfinyl)-octane

    ITC found in Nasturtium officinale (watercress)...

    ≥98%
  • A5278

    Angiotensin III, human

    Endogenous peptide, cleavage product of AT II; ...

    ≥95%
  • O938565

    6-Oxodocetaxel

    Docetaxel impurity

    ≥98%
  • A7202

    AS-604850

    p110γ PI3K inhibitor.

    ≥98%
  • A5160

    Ampicillin Trihydrate

    β-lactam; transpeptidase inhibitor.

    ≥97%
  • M9608

    Myclobutanil

    14-α demethylase inhibitor.

    ≥97%

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2025 LKT Laboratories, All Rights Reserved - Products for research use only